Stupp, 2015, JAMA, 314, 2535, 10.1001/jama.2015.16669
Nieder, 2006, Crit Rev Oncol Hematol, 60, 181, 10.1016/j.critrevonc.2006.06.007
Stupp, 2005, N Engl J Med, 352, 987, 10.1056/NEJMoa043330
Lee, 2017, Onco Targets Ther, 10, 265, 10.2147/OTT.S120662
Ostrom, 2018, Neuro Oncol, 20, iv1, 10.1093/neuonc/noy131
Daniel, 2019, Front Oncol, 9, 41, 10.3389/fonc.2019.00041
Friedman, 2000, Clin Cancer Res, 6, 2585
Stockwell, 2017, Cell, 171, 273, 10.1016/j.cell.2017.09.021
Cao, 2016, Cell Mol Life Sci, 73, 2195, 10.1007/s00018-016-2194-1
Dixon, 2012, Cell, 149, 1060, 10.1016/j.cell.2012.03.042
Yang, 2014, Cell, 156, 317, 10.1016/j.cell.2013.12.010
Jiang, 2020, Toxicol In Vitro, 62, 104715, 10.1016/j.tiv.2019.104715
Zhang, 2020, Cardiol Res Pract, 2020, 5695723
Wang, 2018, Cancer Lett, 428, 21, 10.1016/j.canlet.2018.04.021
Cheng, 2020, Oncol Rep, 43, 147
Buccarelli, 2018, Cell Death Dis, 9, 841, 10.1038/s41419-018-0864-7
Xue, 2016, Cell Metab, 24, 447, 10.1016/j.cmet.2016.07.015
Cossarizza, 2009, Nat Protoc, 4, 1790, 10.1038/nprot.2009.189
Wang, 2019, Mol Med Rep, 20, 4081
Yang, 2016, Trends Cell Biol, 26, 165, 10.1016/j.tcb.2015.10.014
Dodson, 2019, Redox Biol, 23, 101107, 10.1016/j.redox.2019.101107
Mou, 2019, J Hematol Oncol, 12, 34, 10.1186/s13045-019-0720-y
Lin, 2020, Front Pharmacol, 11, 1061, 10.3389/fphar.2020.01061
Song, 2020, Front Neurosci, 14, 267, 10.3389/fnins.2020.00267
Gao, 2020, Anticancer Drugs, 31, 27, 10.1097/CAD.0000000000000825
Hubert, 2002, Proc Natl Acad Sci U S A, 99, 12345, 10.1073/pnas.192423399
Yu, 2019, Oncol Rep, 42, 826
Li, 2019, J Clin Invest, 129, 2293, 10.1172/JCI126428
Li, 2019, Cells, 8, 198, 10.3390/cells8020198
